Estudio económico del paciente diabético en un servicio de angiología y cirugía vascular

Laburpena

Introduction. Diabetes mellitus is one of the main chronic diseases of developed countries, with high economic impact and strong social cost1. Objective. To carry out a study of the health cost of diabetic patients treated in an Angiology and Vascular Surgery service within the Health System of the Junta de Castilla y León (Sacyl) for a period of 1 year. Material and methods. Retrospective study of the processes generated by diabetic patients with arterial pathology treated in the Angiology and Vascular Surgery department for 1 year (2018). A descriptive study and economic analysis of the direct health costs that generate the income of these patients is carried out. The statistical analysis of the sample data is performed with the statistical program G-Stat 2.0.1. During this period 113 patients with 186 processes are included, mean age 72 ± 12.8 years (37-90), 93 men (82.3%), 20 women (17.7%). Results. Of the 113 patients, 11 (5.9%) died, showing CRI (p = 0.0462), dialysis (p = 0.0107), retinopathy (p = 0.0475) and heart disease (p = 0 , 0365). The average time of admission was 16.40 days ± 10.65 days, with an average expenditure of 6,563.02 euros /process. When medical treatment was performed, the average stay was 10 ± 6.87 days with an average cost of 3,955.84 euros / process and surgical treatment average stay of 17.60 ± 11.05 days with an average cost 7197.13 euros / process (p = 0.0008). Minor amputation with an average stay of 18.98 ± 10.52 days and expense for p 7,761.46 euros / process. (p = 0.0003). Major amputation an average stay of 21.27 ± 14.31 days and expense for 9,029.43 euros / process (p = 0.0151). Conclusions. Mortality is higher in diabetic patients with CRF, hemodialysis, retinopathy and heart disease. Health expenditure is higher in patients who undergo surgical treatment (major or minor amputation) due to longer hospital stay. The expense of patients with medical treatment is lower.